Biotech Website Redesign for Clinical-Stage CNS Biopharma
Neuro-Pharmaceutical in Boston, MA gets a biotech website redesign.
Website project overview
Biopharma, CNS Disease
Website Design Makeover
A clinical stage central nervous system (CNS) disease biopharma required a new biotech website redesign to clarify their shift from a multi-asset startup to a Negative Symptoms (NS) biopharma. Negative symptoms include the inability to show emotions, apathy, difficulties talking, and withdrawing from social situations and relationships.
The Minerva team was keenly aware of the opportunity to be first-to-market with a FDA-approved NS drug, but they needed help telling their story. They wanted unique, modern website design with clear messaging, so the creative challenge was to zero in on the critical areas of change in order to reshape the website to reflect Minerva’s novel focus on NS disease.
Minerva’s unique ability to innovate and address unmet needs for patients in large CNS disease groups (schizophrenia, MDD, insomnia and Parkinson’s) presents significant commercial opportunities to investors and partners. Originally a multi-asset CNS biopharma, they realized a shift in focus to NS disease was important because NS is disease agnostic and disease symptoms often overlap.
And since Minerva is the only biopharma with a demonstrable headwind in negative symptoms, it became obvious they needed to change the emphasis on their site to a NS focus. That meant they would require help identifying key audiences and defining personas.
Minerva needed a unique approach to combine science and art into a new, clean, easy-to-navigate website.
The challenge was to come up with a creative solution to boldly position Minerva as a first-to-market opportunity for potential big Pharma partners.
The first step was to learn more about negative symptoms. Robbie Moore, Stellar’s creative director, did this by asking 10 questions as part of an in-depth discovery process. He clarified expertise and goals and began to define the audience personas and what makes them tick. He then created designs and crafted content to speak to the target personas.
The second step required the Robbie to present several design variations with different functionalities. Each design was discussed and evaluated, ultimately settling on a biotech website design that most clearly express Minerva’s goals and focus on NS disease.
The client collaborated through each step of the biotech website redesign makeover, from page design to content (text and graphics) to WordPress development and QA. Our process allowed the client to fine-tune the messaging to speak to potential partners and adjust the design and animations to create an excellent user experience.
One subtle creative touch was the use of conceptual images of trees. These images provide a softer expression of NS disease than photos of patients suffering from schizophrenia or depression. They provide colorful, curiosity-provoking images to balance the clear, explanatory text on the web pages.
The new site is both sensitive and clear, which is exactly what they client was looking for.
Is your biopharma pivoting? We are experts at navigating the complexity of helping you express a new, redefined focus through your website or digital brand. Contact us to discuss your biotech or biopharmaceutical website makeover.